ESBL-positiivisen suolistobakteeriyhteisön karakterisointi ja koostaminen

Bakteerien yleistynyt antibioottiresistenssi on vaarantanut antibioottien tehokkuuden bakteeri-infektioiden hoidossa. ESBL:t (Extended-Spectrum Beta- Lactamases) ovat entsyymejä, jotka antavat kantajabakteerilleen resistenssin useita terveydenhuollossa yleisesti käytettyjä beetalaktaamiantibiootteja...

Full description

Bibliographic Details
Main Author: Paananen, Petra
Other Authors: Matemaattis-luonnontieteellinen tiedekunta, Faculty of Sciences, Bio- ja ympäristötieteiden laitos, Department of Biological and Environmental Science, Jyväskylän yliopisto, University of Jyväskylä
Format: Master's thesis
Language:fin
Published: 2022
Subjects:
Online Access: https://jyx.jyu.fi/handle/123456789/81406
_version_ 1826225786536853504
author Paananen, Petra
author2 Matemaattis-luonnontieteellinen tiedekunta Faculty of Sciences Bio- ja ympäristötieteiden laitos Department of Biological and Environmental Science Jyväskylän yliopisto University of Jyväskylä
author_facet Paananen, Petra Matemaattis-luonnontieteellinen tiedekunta Faculty of Sciences Bio- ja ympäristötieteiden laitos Department of Biological and Environmental Science Jyväskylän yliopisto University of Jyväskylä Paananen, Petra Matemaattis-luonnontieteellinen tiedekunta Faculty of Sciences Bio- ja ympäristötieteiden laitos Department of Biological and Environmental Science Jyväskylän yliopisto University of Jyväskylä
author_sort Paananen, Petra
datasource_str_mv jyx
description Bakteerien yleistynyt antibioottiresistenssi on vaarantanut antibioottien tehokkuuden bakteeri-infektioiden hoidossa. ESBL:t (Extended-Spectrum Beta- Lactamases) ovat entsyymejä, jotka antavat kantajabakteerilleen resistenssin useita terveydenhuollossa yleisesti käytettyjä beetalaktaamiantibiootteja vastaan. ESBL- geenit ovat useimmiten sijoittuneet liikkuviin plasmideihin, jolloin ne voivat levittää resistenssin yhteisön muihin bakteereihin. Vaikka osa ihmisistä kantaa ESBL-bakteereja suolistossaan oireettomasti, ne aiheuttavat lisääntyneen komplikaatioriskin tavanomaistenkin lääketieteellisten toimenpiteiden yhteydessä. Tämän tutkimuksen tavoitteena oli koostaa ESBL-bakteeria suolistossaan kantavan potilaan suolistomikrobiomista synteettinen bakteeriyhteisö ESBL-plasmidien leviämisen tutkimista varten. Ulostenäytteistä eristettyjä bakteereja karakterisoitiin antibioottiresistenssiprofiilin, 16S rRNA– ja genomisekvensoinnin avulla. Lopullinen synteettinen yhteisö koostui viidestä bakteerista, joita olivat Enterococcus faecalis, Citrobacter freundii, Klebsiella sp. ja Comamonas kerstersii sekä ESBL-positiivinen Escherichia coli. Yhteisön stabiilisuutta tutkittiin seitsemän vuorokauden mittaisessa yhteiskasvatuksessa 16S rRNA sekvensoinnin avulla. C. kerstersii -bakteeria lukuun ottamatta kaikki bakteerilajit säilyivät yhteisössä. Konjugaatiokokeissa havaittiin, että ESBL-plasmidien siirtymistä tapahtui pienissä määrin E. coli (JM109(pSU19)) bakteerikantaan. Synteettistä yhteisöä voidaan tulevaisuudessa käyttää liikkuvien plasmidien tutkimiseen kontrolloiduissa olosuhteissa ja näin ollen paremmin ymmärtää suoliston ESBL-kantajuuden riskejä. Antibiotic resistance in bacteria has compromised the effectiveness of antibiotics in treating bacterial infections. Extended-Spectrum Beta-Lactamases (ESBLs) are enzymes that confer multidrug resistance to several beta-lactam antibiotics commonly used in healthcare. ESBL genes are most often located in mobile plasmids, allowing them to spread to other bacteria in a bacterial community. Although some people carry ESBL bacteria in their gut asymptomatically, they may be in increased risk of complications during standard medical procedures. The aim of this study was to assemble a synthetic bacterial community from the intestinal microbiome of a patient carrying ESBL in their gut. This community can be used to study the spread of ESBL plasmids in a controlled system where interspecific bacterial interactions are present. Bacteria were isolated from fecal samples and characterized by their antibiotic resistance profile as well as their 16S rRNA and whole genome sequences. The final synthetic community consisted of five bacteria: Enterococcus faecalis, Citrobacter freundii, Klebsiella sp., Comamonas kerstersii and Escherichia coli, latter of which was ESBL positive. Community stability was studied in a seven-day co-culture by elucidating the community structure by 16S rRNA sequencing. All bacterial species survived in the community, except for C. kerstersii. Conjugation experiments showed that there was a small amount of transfer of ESBL plasmids into the E. coli (JM109 (pSU19)) bacterial strain. In the future, the synthetic community can be used to study mobile plasmids under controlled conditions and thus better understand the risks of intestinal ESBL carriage.
first_indexed 2024-09-11T08:52:15Z
format Pro gradu
free_online_boolean 1
fullrecord [{"key": "dc.contributor.advisor", "value": "Penttinen, Reetta", "language": "", "element": "contributor", "qualifier": "advisor", "schema": "dc"}, {"key": "dc.contributor.advisor", "value": "Jalasvuori, Matti", "language": "", "element": "contributor", "qualifier": "advisor", "schema": "dc"}, {"key": "dc.contributor.author", "value": "Paananen, Petra", "language": "", "element": "contributor", "qualifier": "author", "schema": "dc"}, {"key": "dc.date.accessioned", "value": "2022-06-01T11:18:23Z", "language": null, "element": "date", "qualifier": "accessioned", "schema": "dc"}, {"key": "dc.date.available", "value": "2022-06-01T11:18:23Z", "language": null, "element": "date", "qualifier": "available", "schema": "dc"}, {"key": "dc.date.issued", "value": "2022", "language": "", "element": "date", "qualifier": "issued", "schema": "dc"}, {"key": "dc.identifier.uri", "value": "https://jyx.jyu.fi/handle/123456789/81406", "language": null, "element": "identifier", "qualifier": "uri", "schema": "dc"}, {"key": "dc.description.abstract", "value": "Bakteerien yleistynyt antibioottiresistenssi on vaarantanut antibioottien tehokkuuden bakteeri-infektioiden hoidossa. ESBL:t (Extended-Spectrum Beta- Lactamases) ovat entsyymej\u00e4, jotka antavat kantajabakteerilleen resistenssin useita terveydenhuollossa yleisesti k\u00e4ytettyj\u00e4 beetalaktaamiantibiootteja vastaan. ESBL- geenit ovat useimmiten sijoittuneet liikkuviin plasmideihin, jolloin ne voivat levitt\u00e4\u00e4 resistenssin yhteis\u00f6n muihin bakteereihin. Vaikka osa ihmisist\u00e4 kantaa ESBL-bakteereja suolistossaan oireettomasti, ne aiheuttavat lis\u00e4\u00e4ntyneen komplikaatioriskin tavanomaistenkin l\u00e4\u00e4ketieteellisten toimenpiteiden yhteydess\u00e4. T\u00e4m\u00e4n tutkimuksen tavoitteena oli koostaa ESBL-bakteeria suolistossaan kantavan potilaan suolistomikrobiomista synteettinen bakteeriyhteis\u00f6 ESBL-plasmidien levi\u00e4misen tutkimista varten. Ulosten\u00e4ytteist\u00e4 eristettyj\u00e4 bakteereja karakterisoitiin antibioottiresistenssiprofiilin, 16S rRNA\u2013 ja genomisekvensoinnin avulla. Lopullinen synteettinen yhteis\u00f6 koostui viidest\u00e4 bakteerista, joita olivat Enterococcus faecalis, Citrobacter freundii, Klebsiella sp. ja Comamonas kerstersii sek\u00e4 ESBL-positiivinen Escherichia coli. Yhteis\u00f6n stabiilisuutta tutkittiin seitsem\u00e4n vuorokauden mittaisessa yhteiskasvatuksessa 16S rRNA sekvensoinnin avulla. C. kerstersii -bakteeria lukuun ottamatta kaikki bakteerilajit s\u00e4ilyiv\u00e4t yhteis\u00f6ss\u00e4. Konjugaatiokokeissa havaittiin, ett\u00e4 ESBL-plasmidien siirtymist\u00e4 tapahtui pieniss\u00e4 m\u00e4\u00e4rin E. coli (JM109(pSU19)) bakteerikantaan. Synteettist\u00e4 yhteis\u00f6\u00e4 voidaan tulevaisuudessa k\u00e4ytt\u00e4\u00e4 liikkuvien plasmidien tutkimiseen kontrolloiduissa olosuhteissa ja n\u00e4in ollen paremmin ymm\u00e4rt\u00e4\u00e4 suoliston ESBL-kantajuuden riskej\u00e4.", "language": "fi", "element": "description", "qualifier": "abstract", "schema": "dc"}, {"key": "dc.description.abstract", "value": "Antibiotic resistance in bacteria has compromised the effectiveness of antibiotics in treating bacterial infections. Extended-Spectrum Beta-Lactamases (ESBLs) are enzymes that confer multidrug resistance to several beta-lactam antibiotics commonly used in healthcare. ESBL genes are most often located in mobile plasmids, allowing them to spread to other bacteria in a bacterial community. Although some people carry ESBL bacteria in their gut asymptomatically, they may be in increased risk of complications during standard medical procedures. The aim of this study was to assemble a synthetic bacterial community from the intestinal microbiome of a patient carrying ESBL in their gut. This community can be used to study the spread of ESBL plasmids in a controlled system where interspecific bacterial interactions are present. Bacteria were isolated from fecal samples and characterized by their antibiotic resistance profile as well as their 16S rRNA and whole genome sequences. The final synthetic community consisted of five bacteria: Enterococcus faecalis, Citrobacter freundii, Klebsiella sp., Comamonas kerstersii and Escherichia coli, latter of which was ESBL positive. Community stability was studied in a seven-day co-culture by elucidating the community structure by 16S rRNA sequencing. All bacterial species survived in the community, except for C. kerstersii. Conjugation experiments showed that there was a small amount of transfer of ESBL plasmids into the E. coli (JM109 (pSU19)) bacterial strain. In the future, the synthetic community can be used to study mobile plasmids under controlled conditions and thus better understand the risks of intestinal ESBL carriage.", "language": "en", "element": "description", "qualifier": "abstract", "schema": "dc"}, {"key": "dc.description.provenance", "value": "Submitted by Miia Hakanen (mihakane@jyu.fi) on 2022-06-01T11:18:23Z\nNo. of bitstreams: 0", "language": "en", "element": "description", "qualifier": "provenance", "schema": "dc"}, {"key": "dc.description.provenance", "value": "Made available in DSpace on 2022-06-01T11:18:23Z (GMT). No. of bitstreams: 0\n Previous issue date: 2022", "language": "en", "element": "description", "qualifier": "provenance", "schema": "dc"}, {"key": "dc.format.extent", "value": "57", "language": "", "element": "format", "qualifier": "extent", "schema": "dc"}, {"key": "dc.format.mimetype", "value": "application/pdf", "language": null, "element": "format", "qualifier": "mimetype", "schema": "dc"}, {"key": "dc.language.iso", "value": "fin", "language": null, "element": "language", "qualifier": "iso", "schema": "dc"}, {"key": "dc.rights", "value": "In Copyright", "language": "en", "element": "rights", "qualifier": null, "schema": "dc"}, {"key": "dc.title", "value": "ESBL-positiivisen suolistobakteeriyhteis\u00f6n karakterisointi ja koostaminen", "language": "", "element": "title", "qualifier": null, "schema": "dc"}, {"key": "dc.type", "value": "master thesis", "language": null, "element": "type", "qualifier": null, "schema": "dc"}, {"key": "dc.identifier.urn", "value": "URN:NBN:fi:jyu-202206013030", "language": "", "element": "identifier", "qualifier": "urn", "schema": "dc"}, {"key": "dc.type.ontasot", "value": "Pro gradu -tutkielma", "language": "fi", "element": "type", "qualifier": "ontasot", "schema": "dc"}, {"key": "dc.type.ontasot", "value": "Master\u2019s thesis", "language": "en", "element": "type", "qualifier": "ontasot", "schema": "dc"}, {"key": "dc.contributor.faculty", "value": "Matemaattis-luonnontieteellinen tiedekunta", "language": "fi", "element": "contributor", "qualifier": "faculty", "schema": "dc"}, {"key": "dc.contributor.faculty", "value": "Faculty of Sciences", "language": "en", "element": "contributor", "qualifier": "faculty", "schema": "dc"}, {"key": "dc.contributor.department", "value": "Bio- ja ymp\u00e4rist\u00f6tieteiden laitos", "language": "fi", "element": "contributor", "qualifier": "department", "schema": "dc"}, {"key": "dc.contributor.department", "value": "Department of Biological and Environmental Science", "language": "en", "element": "contributor", "qualifier": "department", "schema": "dc"}, {"key": "dc.contributor.organization", "value": "Jyv\u00e4skyl\u00e4n yliopisto", "language": "fi", "element": "contributor", "qualifier": "organization", "schema": "dc"}, {"key": "dc.contributor.organization", "value": "University of Jyv\u00e4skyl\u00e4", "language": "en", "element": "contributor", "qualifier": "organization", "schema": "dc"}, {"key": "dc.subject.discipline", "value": "Solu- ja molekyylibiologia", "language": "fi", "element": "subject", "qualifier": "discipline", "schema": "dc"}, {"key": "dc.subject.discipline", "value": "Cell and molecular biology", "language": "en", "element": "subject", "qualifier": "discipline", "schema": "dc"}, {"key": "yvv.contractresearch.funding", "value": "0", "language": "", "element": "contractresearch", "qualifier": "funding", "schema": "yvv"}, {"key": "dc.type.coar", "value": "http://purl.org/coar/resource_type/c_bdcc", "language": null, "element": "type", "qualifier": "coar", "schema": "dc"}, {"key": "dc.rights.accesslevel", "value": "openAccess", "language": null, "element": "rights", "qualifier": "accesslevel", "schema": "dc"}, {"key": "dc.type.publication", "value": "masterThesis", "language": null, "element": "type", "qualifier": "publication", "schema": "dc"}, {"key": "dc.subject.oppiainekoodi", "value": "4013", "language": "", "element": "subject", "qualifier": "oppiainekoodi", "schema": "dc"}, {"key": "dc.subject.yso", "value": "bakteerit", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "suolisto", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "antibioottiresistenssi", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.format.content", "value": "fulltext", "language": null, "element": "format", "qualifier": "content", "schema": "dc"}, {"key": "dc.rights.url", "value": "https://rightsstatements.org/page/InC/1.0/", "language": null, "element": "rights", "qualifier": "url", "schema": "dc"}, {"key": "dc.type.okm", "value": "G2", "language": null, "element": "type", "qualifier": "okm", "schema": "dc"}]
id jyx.123456789_81406
language fin
last_indexed 2025-02-18T10:56:46Z
main_date 2022-01-01T00:00:00Z
main_date_str 2022
online_boolean 1
online_urls_str_mv {"url":"https:\/\/jyx.jyu.fi\/bitstreams\/55106439-8551-41bb-9879-3920b6c965ff\/download","text":"URN:NBN:fi:jyu-202206013030.pdf","source":"jyx","mediaType":"application\/pdf"}
publishDate 2022
record_format qdc
source_str_mv jyx
spellingShingle Paananen, Petra ESBL-positiivisen suolistobakteeriyhteisön karakterisointi ja koostaminen Solu- ja molekyylibiologia Cell and molecular biology 4013 bakteerit suolisto antibioottiresistenssi
title ESBL-positiivisen suolistobakteeriyhteisön karakterisointi ja koostaminen
title_full ESBL-positiivisen suolistobakteeriyhteisön karakterisointi ja koostaminen
title_fullStr ESBL-positiivisen suolistobakteeriyhteisön karakterisointi ja koostaminen ESBL-positiivisen suolistobakteeriyhteisön karakterisointi ja koostaminen
title_full_unstemmed ESBL-positiivisen suolistobakteeriyhteisön karakterisointi ja koostaminen ESBL-positiivisen suolistobakteeriyhteisön karakterisointi ja koostaminen
title_short ESBL-positiivisen suolistobakteeriyhteisön karakterisointi ja koostaminen
title_sort esbl positiivisen suolistobakteeriyhteisön karakterisointi ja koostaminen
title_txtP ESBL-positiivisen suolistobakteeriyhteisön karakterisointi ja koostaminen
topic Solu- ja molekyylibiologia Cell and molecular biology 4013 bakteerit suolisto antibioottiresistenssi
topic_facet 4013 Cell and molecular biology Solu- ja molekyylibiologia antibioottiresistenssi bakteerit suolisto
url https://jyx.jyu.fi/handle/123456789/81406 http://www.urn.fi/URN:NBN:fi:jyu-202206013030
work_keys_str_mv AT paananenpetra esblpositiivisensuolistobakteeriyhteisönkarakterisointijakoostaminen